|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1995-5-24
|
|
pubmed:abstractText |
Prostate-specific antigen (PSA) is an important marker for prostate cancer and has been shown to be secreted from the primary tumor and from metastases. However, the relative contribution of the primary and micrometastatic disease to the serum level of PSA in patients with clinically localized disease has not been delineated. This study addresses the source of pretreatment serum PSA in patients with clinically localized disease.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
30
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
21-32
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:7536722-Adult,
pubmed-meshheading:7536722-Aged,
pubmed-meshheading:7536722-Follow-Up Studies,
pubmed-meshheading:7536722-Humans,
pubmed-meshheading:7536722-Male,
pubmed-meshheading:7536722-Middle Aged,
pubmed-meshheading:7536722-Neoplasm Metastasis,
pubmed-meshheading:7536722-Neoplasm Staging,
pubmed-meshheading:7536722-Prostate-Specific Antigen,
pubmed-meshheading:7536722-Prostatectomy,
pubmed-meshheading:7536722-Prostatic Neoplasms,
pubmed-meshheading:7536722-Regression Analysis,
pubmed-meshheading:7536722-Time Factors,
pubmed-meshheading:7536722-Tumor Markers, Biological
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
The source of pretreatment serum prostate-specific antigen in clinically localized prostate cancer--T, N, or M?
|
|
pubmed:affiliation |
Department of Clinical Radiotherapy, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
